Sattel, H., C. Lahmann, H. Gundel, E. Guthrie, J. Kruse, M. Noll-Hussong, C. Ohmann, J. Ronel, M. Sack, N. Sauer, G. Schneider, and P. Henningsen. 2012. Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: Randomised controlled trial. British Journal of Psychiatry 200:60-67.

Sharpe, M., J. Walker, C. Williams, J. Stone, J. Cavanagh, G. Murray, I. Butcher, R. Duncan, S. Smith, and A. Carson. 2011. Guided self-help for functional (psychogenic) symptoms: A randomized controlled efficacy trial. Neurology 77(6):564-572.

Shea, B. J., J. M. Grimshaw, G. A. Wells, M. Boers, N. Andersson, C. Hamel, A. C. Porter, P. Tugwell, D. Moher, and L. M. Bouter. 2007. Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 7(10).

Strack, B., R. Gevirtz, and W. Sime. 2004. Effect of heart rate variability (HRV) biofeedback on batting performance in baseball. Applied Psychophysiology and Biofeedback 29(4):299.

Sumathipala, A. 2007. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosomatic Medicine 69(9):889-900.

Sumathipala, A., S. Hewege, R. Hanwella, and A. H. Mann. 2000. Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: A feasibility study in Sri Lanka. Psychological Medicine 30(4):747-757.

Sumathipala, A., S. Siribaddana, M. Abeysingha, P. De Silva, M. Dewey, M. Prince, and A. Mann. 2008. Cognitive-behavioural therapy v. structured care for medically unexplained symptoms: Randomised controlled trial. British Journal of Psychiatry 193(1):51-59.

Tanis, C. 2008. The effects of heart rhythm variability biofeedback with emotional regulation on the athletic performance of women collegiate volleyball players. Dissertation Abstracts International: Section B: Sciences and Engineering 69(4-B):2666.

van Rood, Y. R., and C. de Roos. 2009. EMDR in the treatment of medically unexplained symptoms: A systematic review. Journal of EMDR Practice and Research 3(4):248-263.

Volz, H. P., H. J. Moller, I. Reimann, and K. D. Stoll. 2000. Opipramol for the treatment of somatoform disorders: Results from a placebo-controlled trial. European Neuropsychopharmacology 10(3):211-217.

Volz, H. P., H. Murck, S. Kasper, and H. J. Moller. 2002. St. John’s wort extract (Li 160) in somatoform disorders: Results of a placebo-controlled trial. Psychopharmacology (Berl) 164(3):294-300.

Yamada, K., R. Den, K. Ohnishi, and S. Kanba. 2005. Effectiveness of herbal medicine (Kampo) and changes of quality of life in patients with somatoform disorders. Journal of Clinical Psychopharmacology 25(2):199-201.

Zaby, A., J. Heider, and A. Schroder. 2008. Waiting, relaxation, or cognitive-hehavioral therapy: How effective is outpatient group therapy for somatoform symptoms? Zeitschrift für Klinische Psychologie und Psychotherapie 37(1):15-23.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement